🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
0.7904
+0.0423 (5.65%)
Nov 18, 2026, 12:45 PM EST - Market open

iBio, Inc. Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, iBio, Inc. stock has a consensus rating of "Strong Buy" and an average price target of $5.69. The average 1-year stock price forecast is 619.76% higher than the current stock price, while the lowest is $4.20 (+431.38%) and the highest is $7.00 (+785.63%).

Price Target: $5.69 (+619.76%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$4.20$5.69$6.00$7.00
Change+431.38%+619.76%+659.11%+785.63%

Analyst Ratings

The average analyst rating for iBio, Inc. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy777888
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total888999

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
Leerink Partners
No rating
Leerink Partners
Buy
Reiterates
$0.71
BuyReiterates$0.71-10.17%Nov 17, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$7
BuyReiterates$7+785.63%Nov 13, 2026
B. Riley Securities
B. Riley Securities
Buy
Initiates
$6
BuyInitiates$6+659.11%Aug 31, 2026
LifeSci Capital
LifeSci Capital
Buy
Maintains
$5
BuyMaintains$5+532.59%Aug 28, 2026
Chardan Capital
Chardan Capital
Buy
Reiterates
$5
BuyReiterates$5+532.59%Jul 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.09M
from 100.00K
Increased by 987.50%
Revenue Next Year
220.00K
from 1.09M
Decreased by -79.77%
EPS This Year
-0.33
from -0.32
EPS Next Year
-0.52
from -0.33
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
1.88M-225.00K400.00K100.00K1.09M
Revenue Growth
-20.54%--77.78%-75.00%987.50%
Gross Profit
1.88M-225.00K400.00K100.00K1.09M
Gross Margin
100.00%-100.00%100.00%100.00%100.00%
Operating Income
-29.70M-28.78M-16.63M-18.60M-30.14M-48.64M
Net Income
-50.30M-65.01M-24.91M-18.38M-33.04M-47.28M
EPS
-----0.32-0.33
Free Cash Flow
-----23.80M-64.40M
No. Analysts
-----6
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High1.1M
Avg1.1M
Low1.1M

Revenue Growth

Revenue Growth202720282029
High
1,000.0%
Avg
987.5%
Low
975.0%

EPS Forecast

EPS202720282029
High-0.22
Avg-0.33
Low-0.71

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-